EDP Biotech Corporation Begins Early Commercialization Process During Medica Trade Fair
11/24/2010 9:34:18 AM
KNOXVILLE, Tenn.--(BUSINESS WIRE)--EDP Biotech, U.S.-based developer of ColoMarker™, an innovative blood test to detect the early stages of colon cancer, has begun its global rollout and early commercialization process. The ColoMarker™ test was previewed during Germany’s 2010 Medica Trade Fair.
comments powered by